Literature DB >> 31368813

Regulating impact on bystanders in clinical trials: An unsettled frontier.

Nir Eyal1, Jonathan Kimmelman2, Lisa G Holtzman3, Marc Lipsitch4.   

Abstract

This article informally reviews key research ethics guidelines and regulations, academic scholarship, and research studies and finds wide variety in how they consider risk to bystanders in medical research (namely, non-participants whom studies nevertheless place at risk). Some of these key sources give no or very little consideration to bystanders, while others offer them the utmost protection (greater than they offer study participants). This unsettled frontier would benefit from a deeper investigation of the ethics of protecting research bystanders.

Entities:  

Keywords:  Research ethics; bystander; clinical ethics; clinical trials; human research subject protection; research nonparticipant; third party consent

Mesh:

Year:  2019        PMID: 31368813      PMCID: PMC6742522          DOI: 10.1177/1740774519862783

Source DB:  PubMed          Journal:  Clin Trials        ISSN: 1740-7745            Impact factor:   2.486


  12 in total

1.  Respect for persons, informed consent and the assessment of infectious disease risks in xenotransplantation.

Authors:  J H Barker; L Polcrack
Journal:  Med Health Care Philos       Date:  2001

2.  Medical research, risk, and bystanders.

Authors:  Jonathan Kimmelman
Journal:  IRB       Date:  2005 Jul-Aug

3.  Protecting third parties in human subjects research.

Authors:  David B Resnik; Richard R Sharp
Journal:  IRB       Date:  2006 Jul-Aug

4.  Missing the forest: further thoughts on the ethics of bystander risk in medical research.

Authors:  Jonathan Kimmelman
Journal:  Camb Q Healthc Ethics       Date:  2007       Impact factor: 1.284

5.  Immunization against poliomyelitis: risk/benefit/cost in a changing context.

Authors:  J Salk
Journal:  Dev Biol Stand       Date:  1979

6.  Third-party risks in research: should IRBs address them?

Authors:  Daniel M Hausman
Journal:  IRB       Date:  2007 May-Jun

7.  A framework for risk-benefit evaluations in biomedical research.

Authors:  Annette Rid; David Wendler
Journal:  Kennedy Inst Ethics J       Date:  2011-06

8.  The ethics of biosafety considerations in gain-of-function research resulting in the creation of potential pandemic pathogens.

Authors:  Nicholas Greig Evans; Marc Lipsitch; Meira Levinson
Journal:  J Med Ethics       Date:  2015-08-28       Impact factor: 2.903

9.  World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.

Authors: 
Journal:  JAMA       Date:  2013-11-27       Impact factor: 56.272

10.  The Ottawa Statement on the Ethical Design and Conduct of Cluster Randomized Trials.

Authors:  Charles Weijer; Jeremy M Grimshaw; Martin P Eccles; Andrew D McRae; Angela White; Jamie C Brehaut; Monica Taljaard
Journal:  PLoS Med       Date:  2012-11-20       Impact factor: 11.069

View more
  2 in total

1.  Minimal or reasonable? Considering the ethical threshold for research risks to nonconsenting bystanders and implications for nonconsenting participants.

Authors:  Holly Fernandez Lynch
Journal:  Bioethics       Date:  2020-02-24       Impact factor: 1.898

2.  Ethical considerations within pragmatic randomized controlled trials in dementia: Results from a literature survey.

Authors:  Stuart G Nicholls; Kelly Carroll; Hayden P Nix; Fan Li; Spencer Phillips Hey; Susan L Mitchell; Charles Weijer; Monica Taljaard
Journal:  Alzheimers Dement (N Y)       Date:  2022-05-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.